Evolocumab Improves Features Of Plaque Stability In patients of ACS: HUYGENS trial Medical Dialogues Bureau30 Aug 2021 12:45 AM GMTUSA: Repatha (evolocumab) in addition to optimized statin therapy, in comparison with optimized statin therapy alone, significantly improved features...
PCSK9 inhibitors may slow progression of aortic stenosis Dr. Kamal Kant Kohli1 May 2020 6:03 AM GMTEvolocumab (Repatha) decreases LDL cholesterol and has significant impact on Myocardial infarction type and size. Researchers in an additional...
